Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.03
-$0.04 (-0.22%)
Sep 22, 2026, 12:22 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -92.04M | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M | -27.72M |
Depreciation & Amortization | 9K | 4K | 3K | -164K | 55K | n/a | n/a | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 8K | 11K | 11K | 10K | 8K | 9K | 16K |
Stock-Based Compensation | 26.07M | 12.05M | 11.25M | 12.08M | 13.79M | 10.38M | 12.3M | 11.93M | 9.9M | 8.9M | 8.33M | 8.32M | 8.07M | 6.24M | 4.24M | 4.36M | 3.94M | 3.48M | 3.93M | 3.38M | 3.24M | 2.77M |
Other Working Capital | 23.73M | -17.27M | 12.29M | -6.68M | -17.37M | -3.59M | 26.46M | 14.95M | -9.32M | -9.25M | 22.1M | 10.42M | -2.14M | -4.19M | 15.67M | -6.61M | 1.96M | -4.58M | 715K | -9.59M | -1.88M | -998K |
Other Non-Cash Items | -19.39M | -676K | -973K | 1.64M | -3.04M | -3.27M | -2.7M | -2.76M | -3.41M | -3.58M | -3.22M | -3.42M | -3.57M | -3.86M | -1.91M | -145K | -9K | 22K | -690K | 401K | 403K | 328K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.73M | -19.05M | -11.76M | -23.38M | -26.75M | -17.43M | 27.19M | 12.63M | -10.07M | -16.47M | 26.01M | 1.59M | 4.75M | -486K | 13.97M | 2.63M | -6.67M | -8.27M | 1.26M | -8.1M | -4.79M | 2.02M |
Operating Cash Flow | -80.62M | -50.35M | -69.49M | -70.54M | -87.8M | -95.16M | -57.39M | -62.32M | -71.65M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.71M | -24.94M | -24.05M | -22.59M |
Capital Expenditures | -40K | n/a | -56K | -131K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -125.26M | -39.39M | -63.12M | -30.44M | -91.71M | -10.54M | -376.31M | -13.35M | n/a | -167.39M | -129.29M | -82.72M | -81.01M | -61.59M | -250.88M | -79.84M | -122.37M | -42.27M | -105.23M | -62.94M | -59.82M | -66.73M |
Sales Maturities Of Investments | 146.78M | 77.78M | 144.75M | 103M | 133.6M | 104.68M | 107.34M | 100.2M | 61.75M | 67.99M | 113M | 122.8M | 154.92M | 81.5M | 113.25M | 72.82M | 72.42M | 50.45M | 45.4M | 89.58M | 81.5M | 37.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | n/a | n/a | -129K | n/a | n/a | n/a |
Investing Cash Flow | 21.48M | 38.39M | 81.58M | 72.43M | 41.89M | 94.14M | -268.97M | 86.85M | 61.75M | -99.4M | -16.29M | 40.08M | 73.91M | 19.92M | -137.63M | -6.79M | -49.95M | 8.18M | -59.96M | 26.63M | 21.68M | -29.23M |
Debt Repayment | 250M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.53M | n/a | n/a | n/a | n/a | 930K | 347.43M | 3.1M | 676K | 2.17M | 389K | 1.85M | 1.32M | 2.47M | 1.14M | -13.53M | 21.72M | 557K | 28.57M | 1.71M | 889K | 960K |
Financial Cash Flow | 260.69M | 7.92M | 5.92M | 6.28M | 551K | 930K | 347.43M | 3.1M | 676K | 2.17M | 258.48M | 1.85M | 1.32M | 2.47M | 163.5M | -13.53M | 21.72M | 557K | 109.78M | 1.71M | 6.02M | 960K |
Net Cash Flow | 201.55M | -4.04M | 18.01M | 8.17M | -45.36M | -90K | 21.06M | 27.62M | -9.22M | -180.78M | 200.84M | -2.73M | 39.86M | -16.84M | 2.98M | -48.86M | -68.53M | -33.19M | 150.53M | 3.39M | 3.66M | -50.86M |
Free Cash Flow | -80.66M | -50.35M | -69.54M | -70.67M | -87.8M | -95.16M | -57.39M | -62.32M | -71.65M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.58M | -24.94M | -24.05M | -22.59M |
Adj. Free Cash Flow | -106.72M | -62.4M | -80.8M | -82.75M | -101.58M | -105.54M | -69.69M | -74.26M | -81.54M | -92.45M | -49.68M | -52.97M | -43.44M | -45.47M | -27.14M | -32.91M | -44.24M | -45.41M | 96.65M | -28.33M | -27.29M | -25.36M |
Maintenance CapEx | -9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -31K | n/a | -56K | -131K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -80.63M | -50.35M | -69.49M | -70.54M | -87.8M | -95.16M | -57.39M | -62.32M | -71.65M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.71M | -24.94M | -24.05M | -22.59M |
Add to Watchlist
Select watchlists to add or remove SNDX